AVITA Medical (RCEL) Cash from Investing Activities (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Cash from Investing Activities (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | AVITA Medical | 310.57 Mn | 299.44 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.21% |
| Sep 30, 2025 | -176.13% |
| Jun 30, 2025 | -34.83% |
| Mar 31, 2025 | 335.69% |
| Dec 31, 2024 | -66.58% |
| Sep 30, 2024 | -40.52% |
| Jun 30, 2024 | -17.48% |
| Mar 31, 2024 | 126.29% |
| Dec 31, 2023 | -363.33% |
| Sep 30, 2023 | 18.50% |
| Jun 30, 2023 | -2.26% |
| Mar 31, 2023 | -66.81% |
| Sep 30, 2021 | -9,440.30% |
| Jun 30, 2021 | -45.30% |
| Mar 31, 2021 | -6.78% |
| Dec 31, 2020 | -14.53% |
| Mar 31, 2020 | -326.60% |
| Dec 31, 2019 | 38.16% |